Nutraceutical Regulations and Registration in European Union (EU-EMA)
At a CAGR of 4.91% over the projected period (2023-2028), the Europe Nutraceutical Market is anticipated to increase from USD […]
EU EMA Compliance
Learn about EMA regulations for pharmaceuticals, biologics, and medical devices across the European Union. Articles cover clinical trial requirements, product approvals, and safety standards to help companies meet EU compliance.
Pharmaceutical Regulations in European Union
The European pharmaceutical market is expected to reach USD 432.12 billion by 2028, growing at a CAGR of 5.4%. Cancer
Biologics & Biosimilar Regulations in European Union (EU) (EMA)
In 2022, the Europe biosimilar market had a value of almost USD 4601.56 million. In addition, it is anticipated that
EMA’s Clinical Trial Regulations (EUCTR) in European Union
The new EU Clinical Trial Regulation (CTR) 536/2014, which came into effect on January 31, 2022, represents a significant overhaul
Medical Device Risk Classification Under EU MDR
The European Union Medical Device Regulation (EU MDR) represents a significant overhaul of the regulatory framework for medical devices in
Medical Devices Regulations in European Union (EU MDR)
The medical devices market in Europe has exhibited impressive value, surpassing USD 140.07 billion in 2022. Experts predict that this
Role of Qualified Person Responsible for Pharmacovigilance (QPPV) in the EU
In the intricate landscape of pharmaceutical regulation, ensuring the safety and efficacy of medicinal products is paramount. At the heart